Search

everythinglearnresearchcommunity

for

Search:↓

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

Certain drugs can cause hair loss, but stopping the drug usually leads to hair regrowth.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

New cytokine-targeted therapies show promise for treating alopecia areata.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Betamethasone injections are more effective than Clobetasol for treating alopecia areata in children.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

In 2021, JAMA Dermatology published significant findings on skin conditions post-COVID vaccination, melanoma surveillance, atopic dermatitis treatments, and confirmed that sun protection does not harm bone health.

Some eczema treatments may cause conjunctivitis, many people have sensitive eyes, air pollution can increase skin wrinkles, hair loss medication does not affect sexual function, and dermatologists can help identify torture signs on refugees' skin.

Biologics for severe asthma have known side effects, but some new risks need more study.

The CDC reports 23 measles cases in unvaccinated US kids, new treatments for eosinophilic esophagitis and osteopenia are approved, poor sleep may cause migraines, atopic dermatitis could lead to asthma, migraines might increase Crohn's disease risk, cancer may raise heart disease risk, gout is linked to prostate issues, Cabo Verde is malaria-free, social factors and vitamin D affect dementia risk, smoking increases hair loss risk, certain drugs might lower thyroid disease risk in arthritis, noma is a neglected disease, and meal timing could impact heart health.

In 2019, dermatology and venereology improved skin cancer imaging, advanced in treating skin conditions like psoriasis, and explored the skin microbiome's role in diseases.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Samcyprone ointment is effective for treating common warts if a sensitization reaction occurs first.

High potency topical steroids are the most effective treatment for pediatric alopecia areata.

Some multiple sclerosis treatments may trigger hair loss conditions like alopecia areata.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Certain proteins, caspases-1 and -11, are important in the early development of skin inflammation in mice.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Exosomes can improve skin health and offer new treatments for skin repair and rejuvenation.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.